Sensus Healthcare (SRTS) Return on Invested Capital (2022)
Sensus Healthcare (SRTS) posted quarterly Return on Invested Capital of 33.15% for Q3 2022, down 140.12% quarter-over-quarter from 13.81% in Q2 2022.
Sensus Healthcare (SRTS) Return on Invested Capital (2022) Analysis & Trends
Sensus Healthcare's Return on Invested Capital history runs 1 years deep, the most recent figure standing at 33.15% for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.01% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.01% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.01% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.01% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.04% |
| 10 | Sensus Healthcare | 54.65 Mn | 39.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -33.15% |
| Jun 30, 2022 | -13.81% |
| Mar 31, 2022 | -8.30% |